Metraipolis › archive › dc_86365cd63a65
Advances in the Developing of SARS-CoV-2 Mpro Inhibitors — Europe PMC PPR:PPR479223
- Source
- Europe PMC
- Original
- https://europepmc.org/article/PPR/PPR479223
- DOI
- 10.20944/preprints202204.0065.v1
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T00:15:21.278Z
- SHA-256 of the archived text
487377a4a676803193c47685173c589f1257a2a85a6d6615eb0b44c4022c7796- Stable URL of this page
https://metraipolis.com/documento/dc_86365cd63a65
How to cite
Advances in the Developing of SARS-CoV-2 Mpro Inhibitors — Europe PMC PPR:PPR479223 — Europe PMC, https://europepmc.org/article/PPR/PPR479223 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_86365cd63a65 (Metraipolis archive dc_86365cd63a65, sha256 487377a4a676803193c47685173c589f1257a2a85a6d6615eb0b44c4022c7796)
BibTeX
@misc{dc86365cd63a65,
title = {Advances in the Developing of SARS-CoV-2 Mpro Inhibitors — Europe PMC PPR:PPR479223},
howpublished = {Europe PMC},
url = {https://europepmc.org/article/PPR/PPR479223},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_86365cd63a65; sha256 487377a4a676803193c47685173c589f1257a2a85a6d6615eb0b44c4022c7796},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/PPR/PPR479223. Agents can read the archived copy with the MCP tool read_document.